Patent 9867852 was granted and assigned to Omrix Biopharmaceuticals on January, 2018 by the United States Patent and Trademark Office.
The invention relates to a viral inactivated biological liquid or dry mixture and to its preparation. Principally, the invention relates, but is not limited, to a mixture derived from a platelet source.